BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1059 related articles for article (PubMed ID: 10078539)

  • 1. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
    Webb DJ; Freestone S; Allen MJ; Muirhead GJ
    Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
    Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
    Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sildenafil citrate on human hemodynamics.
    Jackson G; Benjamin N; Jackson N; Allen MJ
    Am J Cardiol; 1999 Mar; 83(5A):13C-20C. PubMed ID: 10078538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina.
    Webb DJ; Muirhead GJ; Wulff M; Sutton JA; Levi R; Dinsmore WW
    J Am Coll Cardiol; 2000 Jul; 36(1):25-31. PubMed ID: 10898408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent interactions of the hypotensive effects of sildenafil citrate and sublingual glyceryl trinitrate.
    Oliver JJ; Kerr DM; Webb DJ
    Br J Clin Pharmacol; 2009 Apr; 67(4):403-12. PubMed ID: 19371313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall cardiovascular profile of sildenafil citrate.
    Zusman RM; Morales A; Glasser DB; Osterloh IH
    Am J Cardiol; 1999 Mar; 83(5A):35C-44C. PubMed ID: 10078541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sildenafil citrate on blood pressure and heart rate in men with erectile dysfunction taking concomitant antihypertensive medication. Sildenafil Study Group.
    Zusman RM; Prisant LM; Brown MJ
    J Hypertens; 2000 Dec; 18(12):1865-9. PubMed ID: 11132612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological profiles of sildenafil (VIAGRA) in the treatment of erectile dysfunction: efficacy and drug interaction with nitrate].
    Omote M
    Nihon Yakurigaku Zasshi; 1999 Oct; 114(4):213-8. PubMed ID: 10584234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men.
    Mahmud A; Hennessy M; Feely J
    J Hum Hypertens; 2001 Oct; 15(10):707-13. PubMed ID: 11607801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sildenafil augments the beneficial hemodynamic and histopathological effects of amlodipine in nitric oxide-deficient hypertensive rats: role of nitric oxide-cyclic GMP pathway.
    Aboutabl ME; Raafat M; Maklad YA; Kenawy SA; El Din AG
    Pharmacol Res; 2008 Jun; 57(6):456-63. PubMed ID: 18572415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sex, erectile dysfunction, and the heart: a growing problem].
    Görge G; Flüchter S; Kirstein M; Kunz T
    Herz; 2003 Jun; 28(4):284-90. PubMed ID: 12825143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction.
    Goldenberg MM
    Clin Ther; 1998; 20(6):1033-48. PubMed ID: 9916601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease.
    Conti CR; Pepine CJ; Sweeney M
    Am J Cardiol; 1999 Mar; 83(5A):29C-34C. PubMed ID: 10078540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex and the patient with cardiovascular risk factors: focus on sildenafil.
    Kloner RA
    Am J Med; 2000 Dec; 109 Suppl 9A():13S-21S; discussion 29S-30S. PubMed ID: 11137498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective.
    Jackson G; Montorsi P; Cheitlin MD
    Urology; 2006 Sep; 68(3 Suppl):47-60. PubMed ID: 17011375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
    Kloner RA
    Am J Cardiol; 2005 Dec; 96(12B):42M-46M. PubMed ID: 16387566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of sildenafil-induced hypotension is minimal with nitrates generating a radical intermediate.
    Schwemmer M; Bassenge E; Stoeter M; Hartmann B; Hess U; Fink B
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):149-55. PubMed ID: 11444498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial.
    Arruda-Olson AM; Mahoney DW; Nehra A; Leckel M; Pellikka PA
    JAMA; 2002 Feb; 287(6):719-25. PubMed ID: 11851538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of regular phosphodiesterase type 5 inhibition in hypertension.
    Oliver JJ; Melville VP; Webb DJ
    Hypertension; 2006 Oct; 48(4):622-7. PubMed ID: 16940217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects.
    Kruuse C; Thomsen LL; Jacobsen TB; Olesen J
    J Cereb Blood Flow Metab; 2002 Sep; 22(9):1124-31. PubMed ID: 12218418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.